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The histone lysine demethylase KDM5B regulates
gene transcription and cell differentiation and is
implicated in carcinogenesis. It contains multiple
conserved chromatin-associated domains, including
three PHD fingers of unknown function. Here, we
show that the first and third, but not the second,
PHD fingers of KDM5B possess histone binding ac-
tivities. The PHD1 finger is highly specific for unmod-
ified histone H3 (H3K4me0), whereas the PHD3 finger
shows preference for the trimethylated histone mark
H3K4me3. RNA-seq analysis indicates that KDM5B
functions as a transcriptional repressor for genes
involved in inflammatory responses, cell prolifera-
tion, adhesion, and migration. Biochemical analysis
reveals that KDM5B associates with components
of the nucleosome remodeling and deacetylase
(NuRD) complex and may cooperate with the histone
deacetylase 1 (HDAC1) in gene repression. KDM5B is
downregulated in triple-negative breast cancer rela-
tive to estrogen-receptor-positive breast cancer.
Overexpression of KDM5B in the MDA-MB 231
breast cancer cells suppresses cell migration and
invasion, and the PHD1-H3K4me0 interaction is
essential for inhibiting migration. These findings
highlight tumor-suppressive functions of KDM5B in
triple-negative breast cancer cells and suggest aCmultivalent mechanism for KDM5B-mediated tran-
scriptional regulation.
INTRODUCTION
The histone lysine demethylase KDM5B (also known as PLU-1
and JARID1B) regulates gene expression and is implicated in
cancer development and proliferation (Klose et al., 2006).
KDM5B belongs to the KDM5/JARID1 family, which catalyzes
the removal of methyl groups from tri-, di-, and monomethylated
lysine 4 of histone H3 (H3K4me3/2/1), and also includes KDM5A/
RBP2, KDM5C/SMCX, and KDM5D/SMCY in mammals (Chris-
tensen et al., 2007; Iwase et al., 2007; Klose et al., 2007; Yamane
et al., 2007). Both fly and yeast have a single ortholog of KDM5:
theDrosophila Little imaginal disks (Lid) and S. cerevisiae Jhd2p/
Yjr119Cp, respectively (Eissenberg et al., 2007; Lee et al., 2007;
Liang et al., 2007; Secombe et al., 2007; Seward et al., 2007).
The KDM5 proteins have a highly conserved domain architec-
ture. They contain a catalytic JmjN/JmjC domain, a DNA binding
ARID/Bright domain, a C5HC2 zinc finger, and two or three PHD
fingers, with the exception of yeast KDM5, which consists of only
the catalytic module and one PHD finger.
The expression of the KDM5B gene is restricted in normal
adult tissues, except for testes and ovaries, but it is often upre-
gulated in human malignancies, including breast, prostate,
bladder, lung, and cervical cancers, and leukemias (Hayami
et al., 2010; Roesch et al., 2010; Xiang et al., 2007). KDM5B
interacts with transcription factors PAX9, FOXG1, and FOXC2
(reviewed in Cloos et al., 2008) and associates with nuclear
receptors such as estrogen receptor alpha (ERa), androgenell Reports 6, 325–335, January 30, 2014 ª2014 The Authors 325
receptor, and progesterone receptor to repress or promote acti-
vation of target genes (Catchpole et al., 2011; Krishnakumar and
Kraus, 2010; Vicent et al., 2013; Xiang et al., 2007). Microarray
analyses have revealed that KDM5B represses genes of antipro-
liferative and cell-cycle regulators, including the tumor suppres-
sor BRCA1, HOX5A, and metallothioneins in the mammary
epithelial cancer cell line MCF7, while positively regulating
E2F1 and E2F2 in A549 and SW789 cells (Hayami et al., 2010;
Scibetta et al., 2007; Yamane et al., 2007). Knockdown of
KDM5B decreases the growth of MCF7 cells both in vitro and
in vivo, suggesting that KDM5B is required for the proliferation
in this type of cancer (Catchpole et al., 2011; Li et al., 2011;
Yamane et al., 2007).
Recent studies have implicated KDM5B in the continuous
growth of xenografted melanoma cells and metastatic progres-
sion (Roesch et al., 2010), and overexpression of KDM5B in
immortalized normal breast cancer MCF10A cells was found to
enhance cell invasion (Yoshida et al., 2011). However, in addition
to functioning as an oncoprotein, KDM5B has been shown to
possess tumor-suppressive activities. KDM5B associates with
the retinoblastoma (Rb) tumor suppressor, and KDM5B knock-
down phenocopies loss of Rb in Rb-dependent senescence
models (Chicas et al., 2012; Nijwening et al., 2011; Roesch
et al., 2005). Consistent with its tumor-suppression function,
overexpression of KDM5B in the triple-negative breast cancer
cell line MDA-MB 231 inhibits cell migration and invasion poten-
tials (Li et al., 2011). Thus, growing evidence suggests that
KDM5B can act as an oncoprotein or a tumor suppressor in a
cell-type-dependent manner. However, the molecular mecha-
nism by which KDM5B contributes to gene regulation and exerts
opposite functions in carcinogenesis remains unclear.
In this work, we show that KDM5B functions as a broad
transcriptional repressor for genes involved in inflammatory
response, cell proliferation, cell adhesion, and migration in
MDA-MB 231 triple-negative breast cancer cells. Mass spec-
trometry, immunoprecipitation (IP), and genomic analyses
demonstrate that KDM5B associates with components of the
NuRD complex andmay cooperate with the HDAC1 deacetylase
and the CHD4 ATPase in repression. We found that of the three
PHD fingers present in KDM5B, two (PHD1 and PHD3) bind to
histone tails. Whereas PHD1 is highly specific for H3K4me0,
PHD3 is more promiscuous and recognizes H3K4me3 as well
as lower methylation states of H3K4. KDM5B inhibits the migra-
tion and invasion abilities of MDA-MB 231 breast cancer cells,
and binding of the PHD1 finger to H3K4me0 is required to sup-
press cell migration. Together, our data highlight tumor-suppres-
sive functions of KDM5B in triple-negative breast cancer cells
and suggest a multivalent mechanism underlying KDM5B-
dependent repression.
RESULTS AND DISCUSSION
KDM5B Is Downregulated in ER Breast Cancer Cells
Breast cancer is a heterogeneous disease. Molecular profiling
has identified several distinct subtypes of breast cancer, which
correlate with hormone response, patient prognosis, and
response to therapy (Morris and Carey, 2007). KDM5B has
been shown to play a significant role in breast cancer progres-326 Cell Reports 6, 325–335, January 30, 2014 ª2014 The Authorssion and metastatic capacity (Catchpole et al., 2011; Li et al.,
2011; Yamane et al., 2007); however, it remains unclear whether
KDM5B has the same expression and tumorigenic activities in
different subtypes of tumors. To clarify this, we examined the
expression levels of KDM5B in 12 different breast cancer cell
lines (Figure 1A). Cell nuclear extracts were isolated and probed
with anti-KDM5B. In comparison to immortalized ‘‘normal’’
breast cancer cells (76NF2V and MCF-10A), KDM5B was over-
expressed in ER+ cells, including MCF7, T47D, MDA-MB 361,
and UACC 812 (Figure 1A). Surprisingly, we found that the
expression level of KDM5B was significantly lower in ER cells,
including HER2+ SKBR3 andAU565 cells, and the triple-negative
MDA-MB 231, MDA-MB 436, and MDA-MB 468 cells. The triple-
negative subtype of breast cancer is particularly associated with
worse survival prognosis in comparison with ER+ breast can-
cers. To determine the general expression level of KDM5B in
the triple-negative subtype, we analyzed KDM5B gene expres-
sion in breast cancer patients in the Curtis breast tumor data
set available in Oncomine. We observed lower expression levels
of KDM5B in the triple-negative breast cancer patients
compared with patients with the ER+/PR+ subtype (Figure S1;
Table S1).
The differential expression levels of KDM5B imply distinct
roles of this protein in ER+ and ER cancer subtypes. Although
the function of KDM5B in ER+MCF7 cells was previously charac-
terized (Catchpole et al., 2011; Li et al., 2011; Scibetta et al.,
2007; Yamane et al., 2007), little is known about KDM5B activ-
ities in more aggressive ER subtypes. To assess the role of
KDM5B in triple-negative breast cancer, we used two small
hairpin RNAs (shRNAs) that reduced the KDM5B protein level
to different degrees inMDA-MB231 cells. As shown in Figure 1B,
full knockdown of KDM5B led to increased H3K4me3 levels,
which is consistent with the H3K4-specific demethylase activity
of KDM5B. It also indicates that the orthologous KDM5demethy-
lases do not substitute for KDM5B, which has also been
observed in ER+ MCF7 cells (Catchpole et al., 2011; Yamane
et al., 2007).
KDM5B Is Required for Repression of a Set of Genes
Involved in Immune Response and Cell Proliferation
in MDA-MB 231 Cells
To identify KDM5B-regulated genes in MDA-MB 231 cells on a
genome-wide scale, we performed RNA sequencing (RNA-seq)
gene-expression analysis in cells treated with a KDM5B-target
shRNA or a control nontargeting shRNA in duplicates. We iden-
tified 423 genes that were upregulated and 333 genes that were
downregulated in KDM5B knockdown MDA-MB 231 cells (Fig-
ure 1C). These results imply that KDM5B correlates with both
gene activation and repression. Gene Ontology (GO) analysis re-
vealed that KDM5B represses genes involved in immune
response and cell proliferation, as well as regulation of angiogen-
esis, cell adhesion, and migration, whereas downregulated
genes in KDM5B knockdown cells did not cluster (Figure 1C;
Table S2). The expression of the KDM5B-dependent genes
was further validated by quantitative real-time PCR (Figure 1D).
A substantial increase in gene expression was seen in both
KDM5B-knockdown cells, and the extent of upregulation
inversely correlated with the extent of KDM5B knockdown,
Figure 1. KDM5B Is a Broad Transcriptional Repressor
(A) KDM5B is overexpressed in ER-positive (ER+) but downregulated in ER-
negative (ER) breast cancer cells. Western blot analysis of KDM5B protein
levels across a panel of breast cancer cells is shown.
(B) Knockdown of KDM5B leads to increased global H3K4me3 levels. Western
blot analysis of KDM5B and H3K4me3 levels in KDM5B knockdown and
control cells.
(C) KDM5B represses the expression of genes involved in immune response,
proliferation, and migration. A heatmap of up- and downregulated genes in
MDA-MB 231 cells treated with KDM5B-specific shRNA versus control shRNA
is shown. GO analysis of upregulated genes is shown on the right. Down-
regulated genes are not enriched in any specific GO term with false discovery
rate (FDR) < 5 (see Table S2).
(D) Quantitative real-time PCR analysis of the expression of KDM5B-regulated
genes in control and KDM5B knockdown MDA-MB 231 cells. Error bars
represent SEM.
(E) KDM5B ChIP analysis on the promoters of the indicated genes in MDA-MB
231 cells stably expressing Flag-KDM5B. Immunoglobulin G (IgG) is shown as
a negative control. Error bars represent SEM.
See also Figure S1 and Tables S1 and S2.
Csuggesting that the observed differences are caused by the elim-
ination of KDM5B. Furthermore, chromatin IP (ChIP) assays in
KDM5B-overexpressing cells demonstrated that KDM5B binds
to the promoters of these genes, substantiating that these genes
are likely KDM5B direct targets (Figure 1E). Together, these
results suggest that KDM5B represses a set of target genes in
MDA-MB 231 cells.
KDM5BAssociateswith theDeacetylase NuRDComplex
The mechanism underlying transcriptional repression by
KDM5B is not well understood, and the question of whether it re-
lies on the demethylase activity per se or encompasses other
epigenetic processes remains open. To examine whether
KDM5B is capable of associating with other nuclear proteins,
we immunoprecipitated KDM5B from human embryonic kidney
293 (HEK293) cells stably expressing Flag-tagged KDM5B, fol-
lowed by SDS-PAGE and silver staining (Figure 2A). Mass spec-
trometry and western blot analyses of the IP purification showed
that KDM5B coprecipitated with two catalytic subunits of the
NuRD complex (reviewed in Allen et al., 2013). One subunit is
a chromodomain helicase DNA binding protein 4 (CHD4)
ATPase, which hydrolyses ATP necessary for DNA sliding and
repositioning of nucleosomes. The second catalytic subunit is
histone deacetylase 1 (HDAC1), which deacetylates acetylated
lysine residues of histones. Furthermore, two noncatalytic
subunits of NuRD, metastasis-associated 2 (MTA2) and retino-
blastoma binding protein 4 (RBBP4), were also identified. A
direct interaction between KDM5B and HDAC4 was previously
reported (Barrett et al., 2007); therefore, we tested whether
KDM5B is able to associate with HDAC1. CoIP experiments in
cells transfected with Flag-HDAC1 demonstrated that HDAC1
indeed interacts with endogenous KDM5B (Figure 2B). These
data suggest the intriguing possibility of a cooperative action
of the three catalytic components, coupling lysine demethyla-
tion, lysine deacetylation, and ATPase-mediated chromatin
remodeling, all of which are important for transcriptional repres-
sion (Figure 2C).
KDM5BColocalizeswithHDAC1andCHD4atChromatin
To confirm that KDM5B, HDAC1, and CHD4 colocalize in vivo,
we performed an analysis of ChIP-seq data sets generated by
the ENCODE consortium in K562 cells. KDM5B is recruited
to 140,000 genomic regions, and 50% (76,268 out of
140,000) of these regions overlap with the regions occupied by
HDAC1 (Figure 2D). Furthermore, 99% of the CHD4-bound
regions overlap with the KDM5B-HDAC1-bound regions, which
represents 17% (12,811 out of 76,268) of KDM5B-HDAC1
associations. Together, these results suggest a strong co-occu-
pancy of KDM5B with the NuRD complex on the chromatin.
The genome-wide analysis revealed that 50% of the
KDM5B-HDAC1 binding sites overlap with tri-, di-, or mono-
methylated H3K4 (H3K4me3/2/1), which are substrates for
the KDM5B enzymatic activity (Figures 2E and S2). Notably,
95% of the KDM5B-HDAC1-CHD4-bound regions corre-
late with chromatin enriched in H3K4me3, and these regions
comprise 50% of the KDM5B-HDAC1-H3K4me3 over-
lapping regions (Figures 2F and S2). Active, weak, or poised
promoters and enhancers were particularly occupied byell Reports 6, 325–335, January 30, 2014 ª2014 The Authors 327
Figure 2. KDM5B Associates with Compo-
nents of the NuRD Complex
(A) Mass-spectrometric analysis of the KDM5B
protein complex. Silver staining of the IP-purified
complex and the number of peptides and scores of
KDM5B-associated proteins are shown.
(B) CoIP of KDM5B with HDAC1.
(C) A model for the cooperative action of KDM5B
and the NuRD complex.
(D) Venn diagram showing overlap of the KDM5B-,
HDAC1-, and CHD4-bound genomic regions.
(E) Overlaps of the H3K4me3-, KDM5B-HDAC1-,
and KDM5B-HDAC1-CHD4-bound regions are
shown in black.
(F) KDM5, HDAC1, and CHD4 chromatin profiles
over a 50 Kb region of human chromosome 7.
Peaks are indicatedwith a black line and a gray line
over the profiles for KDM5B-HDAC1-CHD4 and
KDM5B-HDAC1, respectively. ChIP-seq data for
H3K4me3 and RNA-seq in K562 cells are shown.
The two lower tracks correspond to the coding
regions containing exons and introns, as well as
DNase I-accessible regions.
See also Figure S2.KDM5B-HDAC1-CHD4. These results imply that KDM5B
colocalizes with the NuRD components at the sites that contain
its substrate (H3K4me3), the removal of which by KDM5B would
yield transcriptionally inactive chromatin.
PHD1 and PHD3 Fingers of KDM5B, but Not PHD2, Have
Histone Binding Activity
KDM5B contains three PHD fingers, the biological roles of which
remain unclear (Figure 3A). Because PHD fingers from other328 Cell Reports 6, 325–335, January 30, 2014 ª2014 The Authorsproteins have recently been shown to
possess histone binding activity, we
generated individual KDM5B PHD finger
constructs (PHD1, PHD2, and PHD3)
and tested these proteins in pull-down
assays and histone peptide microarrays.
Glutathione S-transferase (GST)-fusion
PHD1, PHD2, and PHD3 fingers were
incubated first with biotinylated histone
peptides containing single methyla-
tion marks and then with streptavidin
Sepharose beads. The histone peptide-
bound proteins were detected bywestern
blotting. As shown in Figure 3B, the
KDM5B PHD1 finger recognizes the N
terminus of histone H3, either unmodified
or methylated at Lys9. The second finger
(PHD2) was incapable of histone binding,
whereas the third finger (PHD3) showed
a preference for H3K4me3. This high
specificity was confirmed by using an
extended peptide microarray. The PHD1
finger bound to histone H3 (H3K4me0)
regardless of posttranslational modifica-
tions (PTMs) present on Lys9, Lys14, orLys18, whereas PHD3 was specific for methylated H3K4
(Figure S3).
To examine the effect of the PTMs commonly found in the first
six residues of histone H3 on binding of the KDM5B PHD fingers,
we hybridized these proteins to a PTM librarymicroarray (Figures
3C and 3D). TheGST-tagged PHD fingers were screened against
an extensive library of multiply modified histone peptides (Table
S3). In agreement with the pull-down data, the KDM5B PHD1
finger associated with unmodified histone H3 tail; however,
Figure 3. The KDM5B PHD1 and PHD3 Fingers, but Not PHD2, Show Histone Binding Activity
(A) Schematic representation of the KDM5 family of proteins.
(B) Western blot analysis of GST-KDM5B PHD fingers bound to the indicated biotinylated peptides.
(C and D) GST-KDM5B PHD1 and PHD3were analyzed on a PTM library microarray. Relative average signal intensities are shown in graphs. Error bars represent
SEM from pooled averages of two independent array experiments. A scatterplot of two arrays probed with GST-KDM5B PHD3 is also shown. Blue and red dots
indicate H3K4me3-containing and H3K4me2-containing peptides, respectively. The correlation coefficient was calculated by linear regression analysis using
GraphPad Prism v5. A list of the PTM-containing peptides used in the assays and a complete analysis are provided in Tables S3 and S4, respectively.
See also Figure S3.PTMs on the first six residues of H3 blocked this interaction. In
particular, dimethylation or citrullination of Arg2, phosphoryla-
tion of Thr3, methylation of Lys4, and phosphorylation of Thr6
were not tolerated. On the other hand, binding of the PHD3 finger
to H3K4me3 was affected to a lesser extent. PTMs of Arg2 were
permissible, whereas phosphorylation of Thr3 reduced this inter-
action and phosphorylation of Thr6 further inhibited it.
Mechanism of H3K4me0 Recognition by PHD1
To determine the molecular basis for the interaction between
KDM5B PHD1 and unmodified histone H3, we purified
15N-labeled protein and carried out 1H,15N heteronuclear single
quantum coherence (HSQC) titration experiments (Figure 4).
Addition of the H3K4me0 peptide (aa 1–12 of H3) induced large
chemical-shift changes in the PHD1 finger, indicating direct
binding (Figure 4A). A number of peaks disappeared at a pro-
tein-to-peptide ratio of 1:1 and many changed their positions,
revealing slow-to-intermediate exchange regime on the nuclear
magnetic resonance (NMR) timescale, indicative of a strong
interaction. The precise binding affinity of the KDM5B PHD1
finger for H3K4me0 was found to be 1.5 mM, as measured by
fluorescence spectroscopy (Figure 4E).
To identify residues in the histone binding site of the PHD1
finger, we produced a 13C/15N-labeled KDM5B PHD1 finger.CWe assigned backbone and side-chain 1H, 13C, and 15N
chemical shifts using a set of 3D triple-resonance experiments
and analyzed perturbations in the 1H, 15N HSQC spectra of the
protein upon binding to H3K4me0. Plotting chemical-shift
changes for each backbone amide allowed us to identify the res-
idues of KDM5B PHD1 that were directly or indirectly involved in
the interaction (Figure 4B). The most perturbed residues were
clustered in the middle region of the PHD1 finger sequence, en-
compassing residues E321–C330, and a shorter region around
W351 was perturbed to a lesser degree. To obtain mechanistic
details of the interaction, we used the assigned 13Ca, 13Cb,
1Ha, 15N, and 1HN chemical shifts and a chemical-shift Rosetta
(CS-Rosetta) protocol (Shen et al., 2008) to generate a model
of the apo state. The resulting model showed a typical PHD/
RING finger fold and was superimposed with the structure of
the CHD4 PHD2 finger with an rmsd of 2 A˚. Mapping the
KDM5B residues with significantly perturbed amide resonances
onto the model diagram revealed that these residues are located
in or around the first b strand of the PHD1 finger (Figure 4C). This
binding site is in good agreement with the binding sites seen in
previously determined structures of PHD fingers bound to
H3K4me0 (reviewed in Musselman and Kutateladze, 2011).
To assess the inhibition effect of Lys4 methylation, we charac-
terized the interaction of the KDM5BPHD1 finger with H3K4me1,ell Reports 6, 325–335, January 30, 2014 ª2014 The Authors 329
Figure 4. The PHD1 Finger of KDM5B Is Spe-
cific for H3K4me0
(A) Superimposed 1H,15N HSQC spectra of
KDM5B PHD1 collected upon titration of H3K4me0
peptide. Spectra are color-coded according to the
protein:peptide molar ratio.
(B) Normalized chemical-shift changes observed in
the PHD1 finger upon binding to H3K4me0 as a
function of residue. Differences greater than the
average plus 1 SD, the average plus 0.5 SD, and the
average are shown in red, orange, and yellow,
respectively. An asterisk indicates disappearance
of a signal.
(C) Model of the PHD1 finger fold generated using
assigned 13Ca, 13Cb, 1Ha, 15N, and 1HN chemical
shifts and a CS-Rosetta protocol. The most
perturbed residues of the PHD1 finger in (B) are
colored red and labeled.
(D) Superimposed 1H,15N HSQC spectra of KDM5B
PHD1 collected upon titration with H3K4me0,
H3K4me1, H3K4me2, and H3K4me0 peptides
(residues 1–12 of H3).
(E) Binding affinities of WT KDM5B PHD1 for the
indicated histone peptidesmeasured by tryptophan
fluorescence (a) or NMR (b).
(F) Representative binding curves used to deter-
mine KD values by fluorescence and NMR.H3K4me2, and H3K4me3 peptides by NMR and fluorescence
spectroscopy (Figures 4D and 4E). We found that the PHD1
finger binds to H3K4me1 and H3K4me2 peptides 5- and
100-fold more weakly than it binds to H3K4me0 (Figure 3C).
Trimethylated H3K4me3 peptide caused very small changes in
the protein NMR spectra, indicating an almost negligible associ-
ation in the millimolar range of affinities.
The H3K4me0 Binding Mode Is Conserved
The elongated histone binding site of KDM5B PHD1 and high
sequence similarity suggest that the binding mode of this protein
is similar to that of the AIRE, BHC80, CHD4, and TRIM24 PHD
fingers, and this was supported by mutational analysis (Figures
4C and 5A). 1H,15N HSQC and pull-down experiments showed
that substitution of L326, a conserved hydrophobic residue
preceding the third zinc-coordinating Cys, to a tryptophan abol-
ished interaction of KDM5B PHD1 with H3K4me0 (Figures 5B–
5D). Likewise, replacement of the corresponding hallmark Cys
or Met residues in other H3K4me0-specific PHD fingers with a
bulky tryptophan completely disrupts this binding (Lan et al.,
2007; Musselman et al., 2009). Another distinguishable feature
of the H3K4me0 recognition is the presence of extensive acidic330 Cell Reports 6, 325–335, January 30, 2014 ª2014 The Authorspatches on the surface of a PHD finger that
are involved in electrostatic and hydrogen-
bonding contacts with unmodified lysine
and arginine residues of H3. Although the
KDM5B PHD1 sequence N-terminal to
the first zinc-coordinating Cys is less
acidic than the sequences of other
H3K4me0 binding PHD fingers, KDM5B
contains more acidic residues in the loopconnecting the zinc-coordinating second and third Cys residues,
as well as following the fourth zinc-coordinating Cys (Figure 5A).
Whereas replacement of some surface acidic residues with an
alanine resulted in insoluble proteins, soluble D320A and
D328A mutants showed a decrease in binding to H3K4me0,
corroborating the importance of electrostatic contacts with the
highly basic H3K4me0 tail (Figures 5B–5D).
Although the sequences of human KDM5B PHD1, human
KDM5D PHD1, and a single PHD finger of yeast KDM5 are
very similar, KDM5D and the yeast ortholog bound to
H3K4me0 much more weakly in comparison to KDM5B (Fig-
ure 5A; Figures 5E and 5F, left). The respective equilibrium disso-
ciation constants (KDs) were measured by means of
1H,15N
HSQC titrations and found to be 3.5 mM and 117 mM, respec-
tively. Such a weak association was not enhanced by methyl-
ation of H3K9, aswas found for theCHD4PHDfingers (Figure 5E,
right), and the reduction of the surface negative charge further
diminished it (Figure 5F, right). Notably, the key L326 residue in
the KDM5B sequence is replaced by a phenylalanine in
KDM5D (Figure 5A). Much like a tryptophan in the L326Wmutant
of KDM5B, the bulky phenylalanine may cause steric hindrance,
impeding this interaction. Another critical residue, an invariable
Figure 5. The Molecular Mechanism of the
KDM5B PHD1-H3K4me0 Interaction
(A) Alignment of the PHD finger sequences;
absolutely, moderately, and weakly conserved
residues are colored pink, yellow, and blue,
respectively. Regions that are important for the
interaction with H3K4me0 are indicated by red
bars. Each tenth residue of KDM5B is labeled.
(B) Overlays of 1H,15N HSQC spectra of the PHD1
L326W and D320A mutants collected upon titra-
tion of the H3K4me0 peptide.
(C) Western blot analysis of GST-KDM5B PHD1,
WT, and mutants bound to the biotinylated pep-
tides.
(D) Binding affinities of human KDM5B, human
KDM5D, and yeast KDM5 PHD1 fingers for the
indicated histone peptides measured by trypto-
phan fluorescence (a) or NMR (b). NB, no binding
by western blot (c).
(E and F) Overlays of 1H,15N HSQC spectra of the
PHD1 fingers of KDM5D and yeast KDM5
collected upon titration of the indicated peptides.
Spectra are color-coded according to the pro-
tein:peptide molar ratio.leucine (L324 in KDM5B), is substituted by a threonine in yeast
KDM5, most likely accounting for the decrease in binding
(Figure 5A).
The PHD3 Finger Prefers H3K4me3 but Also Binds
H3K4me0
The amino acid sequence of the PHD3 finger of KDM5B has 70%
identical residues compared with the sequence of the PHD3
finger of KDM5A, including the two tryptophan residues that
were previously shown to be required for binding to H3K4me3
(Wang et al., 2009; Figures 6 and S4). Accordingly, mutation of
the W1502 and W1512 residues in KDM5B PHD3 disrupted
interaction with H3K4me3, whereas replacement of acidic
D1506 with an arginine reduced it (Figures 6C–6E). These results
imply that the mechanism of H3K4me3 recognition by the PHD3
finger of KDM5A is conserved in KDM5B, with W1502 and
W1512 of the KDM5B PHD3 finger most likely being involved
in caging the trimethylammonium group of H3K4me3 and
D1506, contributing to restraining the guanidino group of Arg2
of the histone peptide. Surprisingly, we found that the KDM5B
PHD3 finger shows only a slight preference for the trimethylated
state of H3K4. We compared interactions with histone
H3K4me3/2/1/0 peptides using NMR and fluorescence spec-Cell Reports 6, 325–335troscopy (Figures 6B and 6D). An
almost identical pattern of chemical-
shift changes induced by H3K4me3,
H3K4me2, H3K4me1, and H3K4me0 in
the 1H,15N HSQC spectra of PHD3 sug-
gested that these peptides occupy the
same binding pocket (Figure 6B). The
slow-exchange regime on the NMR
timescale for the methylated peptides
revealed an equally robust interaction.
Even interaction with the unmodified pep-tide was in the slow-to-intermediate exchange, which is indica-
tive of strong binding. In agreement, the binding affinities of the
KDM5B PHD3 finger for all four peptides were in the range of
0.5–4 mM, as measured by fluorescence spectroscopy (Fig-
ure 6D). Together, these data demonstrate that the KDM5B
PHD3 finger binds strongly to either methylated or unmodified
histone H3K4, but it prefers the trimethylated species.
PHD1-H3K4me0 Interaction Is Important for
Suppression of MDA-MB 231 Cell Migration
Our GO analysis of MDA-MB 231 cells suggested that in triple-
negative breast cancer cells, KDM5B represses genes involved
in the regulation of cell adhesion and migration, the two pro-
cesses that are imperative for cancer metastasis. We therefore
sought to examine the role of KDM5B and its PHD fingers in
cell migration and invasion. Consistent with the GO analysis,
knockdown of KDM5B in MDA-MB 231 cells increased the cells’
capability to migrate through the Boyden chambers nearly 2-fold
(Figure 7A), whereas overexpression of KDM5B decreased the
cell migratory potential by 50% (Figure 7B). To determine the
effect of KDM5B on cell invasion potential, MDA-MB-231 cells
were tested in Matrigel-coated chambers. The invaded cells
were fixed, stained with Crystal Violet, and counted using a light, January 30, 2014 ª2014 The Authors 331
Figure 6. The PHD3 Finger of KDM5B Is Se-
lective for H3K4me3
(A) Alignment of the PHD finger sequences;
absolutely, moderately, and weakly conserved
residues are colored pink, yellow, and blue,
respectively. The Lys4me3 binding residues are
indicated by red ovals. Each tenth residue of
KDM5B is labeled.
(B and C) Superimposed 1H,15N HSQC spectra of
KDM5B PHD3, WT, or D1506R collected upon
titration with the indicated peptides.
(D) Binding affinities of the KDM5B PHD3 finger
as measured by tryptophan fluorescence (a) or
NMR (b).
(E) Western blot analysis of GST-KDM5B PHD3,
WT, and mutants bound to the indicated bio-
tinylated peptides.
(F) Representative binding curves used to deter-
mine KD values by fluorescence.
(G) Model for KDM5B anchoring at chromatin and
spreading the transcriptionally inactive state.
See also Figure S4.microscope (Figure 7C). We found that overexpression of
KDM5B reduced the MDA-MB-231 cell invasion potential.
Thus, KDM5B is required to block the migration and invasion
ability of ER-type triple-negative breast cancer cells.
To determine the role of the PHD fingers and their histone
binding in MDA-MB 231 cell migration, we generated cell lines
stably expressing full-length wild-type (WT) KDM5B and
KDM5B mutants harboring loss-of-function mutations either
in the PHD1 finger (L326W and D328A) or in the PHD3 finger
(W1502A) (Figure 7D, right). These stable cell lines were then
used in cell migration assays. As expected, WT KDM5B
decreased cell migration by 50% compared with the control
cells; however, the L326W and D328A mutants of PHD1 that
were impaired in binding to H3K4me0 failed to suppress cell
migration (Figure 7D, left). These results suggest that the
PHD1 finger mutants may act as dominant-negative mutants,
altering the dynamics and interactions of endogenous
KDM5B. In contrast, the W1502A mutant of PHD3 that was
defective in H3K4me3 binding showed an inhibitory effect on
cell migration similar to the effect of the WT protein. These re-
sults suggest that recognition of H3K4me0 by the PHD1 finger
of KDM5B is important for inhibiting migration of MDA-MB332 Cell Reports 6, 325–335, January 30, 2014 ª2014 The Authors231 cancer cells, whereas recognition
of H3K4me3 by the PHD3 finger of
KDM5B is dispensable in suppression
of cell migration.
Conclusions
Previous observations and data pre-
sented in this study demonstrate that
the expression level of KDM5B is highly
cancer cell-type dependent. KDM5B is
downregulated in ER breast cancer
cells, including MDA-MB 231 triple-
negative breast cancer cells, whereas, in
line with previous findings (Hayami et al.,2010; Scibetta et al., 2007; Yamane et al., 2007), it is upregulated
in ER+ breast cancer cells, such asMCF7. Depending on the type
of cancer cells, KDM5B appears to elicit opposite effects, acting
much like other major transcriptional regulators p53 and TGF-b:
in contrast to its tumor-promoting function in MCF7 cells (Catch-
pole et al., 2011; Li et al., 2011; Yamane et al., 2007), KDM5B
inhibits the migration and invasion of MDA-MB 231 cells.
Our structural and biochemical analyses reveal that two of the
PHD fingers of KDM5B, PHD1 and PHD3, associate with histone
tails. The PHD1 finger specifically binds to H3K4me0, and the
PHD3 finger is selective for H3K4me3. Thus, not only does the
KDM5B demethylase erase the H3K4me3/2/1 marks, producing
unmodified H3K4me0, it also reads the target mark and the
product of its own catalytic activity through distinct PHD fingers.
The combination of two ‘‘readers’’ capable of recognizing
distinctive epigenetic marks is likely to have a significant impact
on KDM5B activity. Binding of PHD1 to H3K4me0 may provide
an anchoringmechanism for KDM5B to senseH3K4me3 through
PHD3 and slide along the H3K4me3-enriched promoters, deme-
thylating nearby methylated H3K4 and further spreading the
transcriptionally inactive state of chromatin (Figure 6G). Further-
more, the ability of the PHD3 finger to bind unmodified H3 aswell
Figure 7. KDM5B Represses Cell Migration in a PHD1-Dependent
Manner
(A) Knockdown of KDM5B increases cell migration. Representative views of
cells that migrated through the Boyden chambers. An averaged migration
activity of KDM5B knockdown cells (relative to control cells) from three inde-
pendent experiments is shown on the right.
(B and C) Overexpression of KDM5B represses cell migration and invasion
activities of MDA-MB 231 cells. Representative views of cells that migrated
through the Boyden chambers (B) or extracellular matrix-coated chambers (C)
are shown. Averaged migration (B) and invasion activity (C) of KDM5B-
expressing cells (relative to control cells) from three independent experiments
are shown on the right. Error bars represent SEM.
(D) Repression of cell migration by KDM5B requires histone binding of PHD1,
but not histone binding of PHD3. Shown are averaged cell migration activities
of MDA-MB 231 cells expressing WT or mutated PHD1 and PHD3 (left), and
expression levels of the KDM5B proteins (right).implies that the sliding process may also occur when the
H3K4me3 level is low.
The finding that KDM5B is copurified and colocalizes with
components of the NuRD complex indicates that KDM5B and
NuRD may cooperate in transcriptional repression (Figure 2C).
The NuRD complex contains two catalytic subunits, the deace-
tylase HDAC1 and the CHD4ATPase, both of which are essential
for the regulation of gene expression and chromatin remodeling.CThe cooperative action of the three catalytic proteins—KDM5B,
HDAC1, and CHD4—links H3K4 demethylation, lysine deacety-
lation, and ATPase-mediated chromatin remodeling and can
provide a powerful mechanism for a rapid shutoff of actively tran-
scribed genes (Figure 2C). Multiple contacts of other NuRD com-
ponents with chromatin likely add another layer of complexity.
Histone-binding activities of two PHD fingers of CHD4 and the
WD40 domain of RBBP7/4, as well as DNA binding by the
ARID domain of KDM5B and two chromodomains of CHD4
may fine-tune the affinity and specificity of this gene repressive
machinery (Bouazoune et al., 2002; Murzina et al., 2008; Mussel-
man et al., 2009; Scibetta et al., 2007). Future functional studies
are necessary to establish the importance of crosstalk between
these epigenetic components in KDM5B-mediated transcrip-
tional repression.
EXPERIMENTAL PROCEDURES
NMR Spectroscopy and Sequence-Specific Resonance
Assignments
NMR experiments were performed at 298K on a Varian INOVA 600 MHz
spectrometer equipped with a cryogenic probe. For backbone assignments,
uniformly 15N- and 13C-labeled KDM5B PHD1 (1 mM in Tris-HCl buffer pH
6.8, 150 mM NaCl, 15 mM dithiothreitol, and 8% D2O) was used to perform
3D triple-resonance HNCACB, CBCA(CO)NH, C(CO)NH, and HC(CO)NH
experiments as described previously (Ali et al., 2013). The NMR data were pro-
cessed with nmrPipe (Delaglio et al., 1995) and analyzed with nmrDraw. Initial
sequence-specific assignments were obtained in the PINE program and
completed using CcpNMR Analysis v1.6 (Vranken et al., 2005).
Chemical-shift perturbation experiments were carried out using 0.1 mM
uniformly 15N-labeled WT or mutated KDM5B PHD1, KDM5B PHD3, KDM5D
PHD1, and yeast KDM5PHD fingers. The 1H,15NHSQC spectra were recorded
in the presence of increasing concentrations of 12-mer histone tail peptides
(synthesized by the University of Colorado Denver Peptide Core Facility).
The KD values were determined by a nonlinear least-squares analysis in





ð½L+ ½P+KdÞ2  4½P½L
q 
2½P
where [L] is concentration of the peptide, [P] is the concentration of the protein,
Dd is the observed chemical shift change, and Ddmax is the normalized chem-
ical-shift change at saturation. Normalized (Grzesiek et al., 1996) chemical-





where Dd is the change in chemical shift in parts per million (ppm).
Fluorescence Spectroscopy
Spectra were recorded at 25C on a Fluoromax-3 spectrofluorometer
(HORIBA). Samples containing KDM5B PHD1 and PHD3 fingers in PBS buffer
andprogressively increasingconcentrationsof thehistonepeptidewere excited
at 295 nm or 280 nm. Emission spectra were recorded over a range of wave-
lengths between 305 and 405 nm with a 0.5 nm step size and a 1 s integration
time. Three scans were averaged and recorded. KD values were calculated





ð½L+ ½P+KdÞ2  4½P½L
q 
2½P
where [L] is the concentration of the histone peptide, [P] is the concentration of
KDM5B PHD1 or KDM5B PHD3, DI is the observed change of signal intensity,
and DImax is the difference in signal intensity of the free and bound states of the
PHD finger. KD represents the average of three separate experiments (two for
the PHD1-H3K4me2 interaction), with error computed as the SD between
those values.ell Reports 6, 325–335, January 30, 2014 ª2014 The Authors 333
Cell Migration and Invasion Assays
Cell migration and invasion assays were performed as described previously
using Boyden chambers (BD Biosciences) and modified Boyden chambers
coated with Matrigel matrix (Li et al., 2011). MDA-MB 231 cells (1 3 105)
were starved for 16–20 hr in Dulbecco’s modified Eagle’s medium containing
0.1% BSA, and then in 300 ml serum-free medium, and were placed in the up-
per chamber of the transwell. The chambers were then transferred to 24-well
plates containing 500 ml of media supplemented with 10% fetal bovine serum
in each well and were incubated for less than 24 hr at 37C. Noninvading cells
were removed by wiping the upper side of the membrane, and the invaded
cells were fixed and stained with Crystal Violet. The number of invaded cells
was counted under a light microscope from at least five fields and three exper-
iments. The average numbers from the three experiments were calculated be-
tween control and the samples using Student’s t test.
SUPPLEMENTAL INFORMATION
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